The expressions and clinical significances of AR in prostate carcinoma

Jiang Tao,Li Xiancheng,Song Xishuang,Jiang Hui

DOI: https://doi.org/10.3969/j.issn.1008-0848.2005.06.010

2005-01-01

Abstract:Objective To investigate the expression and clinical significance of AR in prostatic carcinoma (PCa), and evaluate if it could be a prognostic molecular marker for PCa. Methods Formalin-fixed, paraffin-embedded tissue sections from 45 cases of (PCa) and 10 cases of benign prostate hyperplasia. (BPH) were analyzed retrospectively by means of immunohis-tochemical Elivison staining method. The relationships of AR expression with PCa stage, grade, PSA, endocrine curative effect and survival time were evaluated at same time. Results The positive staining rates of AR protein expression were 90% and 93.3% in patients with PCa and BPH respectively (P > 0.05), and 100% and 87.5% in PCa patients with different pathology stage (D stage and A-C stage)respectively (P > 0.05). But the degree of positive AR expression was significantly higher in D stage prostate cancer than that in A-C stage Pca (P < 0.05); The positive staining rates of AR protein expression were 85.7% and 100% in PCa patients with different pathology grade (Gleason scores ≤ 7 and Gleason scores > 7) respectively (P > 0.05) and 80% and 97.1% in PCa patients with different PSA value (PSA ≤10ng/mL and PSA > 10ng/mL) respectively (P>0.05). But the degree of positive AR expression was significantly higher in high PSA group (PSA>10ng/mL) than that in low PSA group (PSA≤10ng/mL) of PCa (P < 0.05); Conclusion Although the expression of AR could not be regarded as a prognostic molecular marker for PCa, the degree of positive AR expression were correlated with tumor grades, stages and PSA value. It may be a valuable reference in forecasting biological behavior and prognosis of PCa.